Australian Clinical Labs Ltd

AU:ACL Australia Diagnostics & Research
Market Cap
$239.30 Million
AU$386.47 Million AUD
Market Cap Rank
#14607 Global
#190 in Australia
Share Price
AU$2.02
Change (1 day)
+0.00%
52-Week Range
AU$2.02 - AU$3.19
All Time High
AU$5.09
About

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veter… Read more

Australian Clinical Labs Ltd (ACL) - Total Liabilities

Latest total liabilities as of December 2025: AU$411.46 Million AUD

Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) has total liabilities worth AU$411.46 Million AUD as of December 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Australian Clinical Labs Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Australian Clinical Labs Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Australian Clinical Labs Ltd Competitors by Total Liabilities

The table below lists competitors of Australian Clinical Labs Ltd ranked by their total liabilities.

Liability Composition Analysis (2016–2025)

This chart breaks down Australian Clinical Labs Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.59 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.11 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.73 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.73 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Australian Clinical Labs Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Australian Clinical Labs Ltd (2016–2025)

The table below shows the annual total liabilities of Australian Clinical Labs Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-06-30 AU$402.86 Million 0.00%
2024-12-31 AU$402.86 Million -2.99%
2024-06-30 AU$415.30 Million 0.00%
2023-12-31 AU$415.30 Million +2.23%
2023-06-30 AU$406.24 Million 0.00%
2022-12-31 AU$406.24 Million +2.72%
2022-06-30 AU$395.49 Million 0.00%
2021-12-31 AU$395.49 Million +0.69%
2021-06-30 AU$392.79 Million 0.00%
2020-12-31 AU$392.79 Million +32.22%
2020-06-30 AU$297.06 Million 0.00%
2019-12-31 AU$297.06 Million +135.41%
2019-06-30 AU$126.19 Million 0.00%
2018-12-31 AU$126.19 Million +11.08%
2018-06-30 AU$113.60 Million 0.00%
2017-12-31 AU$113.60 Million +6.40%
2017-06-30 AU$106.77 Million 0.00%
2016-12-31 AU$106.77 Million --